Join our team

Help innovators tell a stronger value story for medicines that matter.

No Patient Left Behind is hiring a full-time Health Economist to help advance our Generalized Cost-Effectiveness Analysis (GCEA) work and support a growing need across the biotech ecosystem: helping innovators, investors, policymakers, and the public better understand the full societal value of innovative medicines.

This role sits at the intersection of health economics, policy, biomedical innovation, and value communication. The Health Economist will help apply and advance GCEA, conduct rigorous policy-relevant analyses, and work directly with innovators at different stages of development to quantify and communicate the value their medicines can bring to patients and society.

Why this role matters

Too often, the value of medicines is discussed narrowly, focusing only on short-term costs while missing the broader benefits that innovation can create for patients, families, caregivers, the healthcare system, and society.

NPLB’s GCEA work is designed to change that.

As Health Economist, you will help build the evidence base for a more complete understanding of value. Your work will help innovators tell stronger, more rigorous value stories, help policymakers better understand the tradeoffs of pricing policy, and help ensure that affordability solutions do not come at the expense of future medical breakthroughs.

Learn more about GCEA + our Value of Medicines work here.

Position Details

Health Economist | Full-Time | Remote (10-15% Travel)

What You’ll Do

Apply GCEA to real-world innovation. Work closely with biotech companies to apply the GCEA framework, quantify the societal value of innovative medicines, and support value communication strategies.

Produce rigorous research. Develop publication-quality models and disseminate findings through peer-reviewed publications, white papers, conference presentations, stakeholder reports, and policy briefs.

Advance value assessment methods. Help develop and validate new approaches to measuring dimensions of value that traditional frameworks often miss, including peace of mind, insurance value, caregiver burden, and scientific spillover.

Inform drug pricing policy. Conduct economic analyses related to major policy debates, including the Inflation Reduction Act, Most Favored Nation, and other price-setting proposals.

Represent NPLB externally. Present original research, build GCEA awareness, and build relationships across the ecosystem at leading conferences such as ISPOR, AcademyHealth, and other HEOR and policy forums.

Who We’re Looking For

Candidates should have:

  • A Ph.D. or master’s degree in health economics, economics, public health, policy analysis, or a closely related field

  • Strong proficiency in cost-effectiveness and cost-benefit modeling

  • Familiarity with U.S. and international health technology assessment (HTA) frameworks, including those used by International HTA agencies such as the National Institute for Health and Care Excellence (NICE), and the Canada's Drug Agency (CDA-AMC), and by non-profit research organizations such as the Institute for Clinical and Economic Review (ICER)

  • Familiarity with GCEA methodology or broader societal value frameworks, including the value flower concept and ISPOR-related reporting standards

  • Strong ability to explain complex quantitative findings to diverse audiences, including executives, investors, clinicians, policymakers, and patient advocates

  • Excellent written communication skills, including experience drafting white papers, manuscripts, policy briefs, or technical reports

Required Qualifications

We are especially interested in candidates with:

  • 1 to 3 years of relevant experience in consulting, academia, research, or industry environments

  • Knowledge of U.S. drug pricing policy, including the Inflation Reduction Act (IRA), and Most Favored Nation (MFN) pricing

  • Experience presenting at national or international health economics conferences

  • Proficiency in R, Python, Excel, or other modeling platforms used in health economic analysis

  • Interest in using emerging tools, including AI-enabled software development tools such as Claude Code, Cursor, or similar platforms

Preferred Qualifications

How to Apply

Please submit a cover letter, resume, and relevant publications or project examples to Halley Ray, Director of Operations at halleyray@nopatientleftbehind.org

In your cover letter, please briefly describe your experience with health economic modeling, your interest in medicine value assessment, and why NPLB’s mission resonates with you.

About No Patient Left Behind

No Patient Left Behind (NPLB) is a network of innovators, investors, economists, healthcare professionals, patients, and others with a stake in a fair and ever improving healthcare system generating both rigorous, independent research and engaging educational materials to support biomedical affordability and innovation.

Affordable innovation requires that we allow market-based pricing of medicines for a patent-intended period of time while relying on proper insurance with low out-of-pocket costs to make all appropriate care accessible to people in need.

We’re building support across the biotech ecosystem

BECOME A FIRST RESPONDER & THOUGHT PARTNER

Sign up to receive action alerts. Help protect access to lifesaving medicines & preserve innovation for those still waiting for a cure.